Filter
  • Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results From APeX-P
    EAACI | 2025 | Hereditary Angioedema (HAE)
  • Assessment of the Effectiveness and Tolerability of Berotralstat for Long-term Prophylaxis in Hereditary Angioedema: Findings from the Berolife Study
    EAACI | 2025 | Hereditary Angioedema (HAE)
  • Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results From a Focus Group
    EAACI | 2025 | Hereditary Angioedema (HAE)
  • Impact of Berotralstat on Quality of Life in Patients with Hereditary Angioedema
    EAACI | 2025 | Hereditary Angioedema (HAE)
  • Berotralstat for the Prevention of Hereditary Angioedema Attacks: Results from the Italian Expanded Access Programme
    C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE)
  • Tolerability and Effectiveness of Berotralstat for Prophylaxis in Adolescents with Hereditary Angioedema: Subgroup Analysis of the Berolife Study
    C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE)
  • Reduction in Percentage of Days With Angioedema Symptoms Among Young Children Initiating Berotralstat: Interim Results From APeX-P
    C1-INH Def Wkshp | 2025 | Hereditary Angioedema (HAE)
  • Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
    ISPOR | 2025 | Hereditary Angioedema (HAE)
  • Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients with C1 Inhibitor Deficiency (Type I/II) and ≥8 Attacks Per Month
    ISPOR | 2025 | Hereditary Angioedema (HAE)
  • Exploring the Role of Disease Burden, Treatment Effectiveness, and Administration Preference on Willingness of Patients With HAE to Change Long-Term Prophylaxis
    AAAAI | 2025 | Hereditary Angioedema (HAE)
Load more >>